(2S,4S)-Boc-4-Phenoxy-pyrrolidine-2-carboxylic acid, 95.0%, 10g

(R)-2-(1-(tert-Butoxycarbonyl)piperidin-3-yl)acetic acid, 95.0%, 5g

Single-channel microliter pipette mLINE® variable, 20 to 200 µl, 1 piece

(TRIFLUOROMETHYL)CYCLOHEXANE, 95%, 1g

1,1,3,3-Tetramethyl-1,3-diethoxydisiloxane, 95%, 1g

2-[4-(Dimethylamino)phenyl]ethanol, 95.0%, 10g

(1-Tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)boronic acid, 97.0%, 100mg

2-(4,4-Difluorocyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate, 95.0%, 25g

N~1~,N~1~-dimethyl-1-(1-methyl-1H-indol-3-yl)ethane-1,2-diamine, 95.0%, 1g

3-Methyl-1H-indazol-6-yl-6-boronic acid, 95.0%, 5g

N-Propargylphthalimide>98.0%(GC)25g

tert-butyl 4-amino-1H-pyrazole-1-carboxylate, 95.0%, 100mg